Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Curriculum for endoscopic treatment of esophageal neoplasia and precursor lesions: ESGE Position Statement - with competency assessment tools.

Created on 25 Sep 2026

Authors

Bas L A M Weusten, Roos E Pouw, Jacques J Bergman, Raf Bisschops, Emmanuel Coron, Pieter Dewint, Peter Elbe, Vicente Lorenzo-Zúñiga, Marcus Hollenbach, Maximilien Barret, Franz L Dumoulin, Wladyslaw Januszewicz, Anastasios Manolakis, Roberta Maselli, Adolfo Parra-Blanco, Stefan Seewald, Vladyslav Yakovenko, David J Tate, Yuichi Mori, Tony C Tham

Published in

Endoscopy. Sep 24, 2026. Epub Sep 24, 2026.

Abstract

Prior to the start of practical training, the trainee should be aware of different treatment modalities and their specific indications and limitations for patients with esophageal neoplasia and precursor lesions.
Before starting the esophageal cancer treatment curriculum, proficiency in management of adverse events such as bleeding, perforation, and strictures, is mandatory.
Competency in optical diagnosis of esophageal (pre)neoplastic lesions is a prerequisite to achieve proficiency in the endoscopic management of early esophageal neoplasia.
Proficiency in both endoscopic resection and endoscopic ablation is mandatory for being considered competent in the endoscopic management of early Barrett neoplasia.
Endoscopic resection in the esophagus should be learned through a structured training program consisting of lectures, live demonstrations, and hands-on training on models, followed by training in humans under strict expert supervision in a hands-on setting. Ideally, a minimum of 10 supervised cases should be done on ex vivo/in vivo models.
In order to maintain competence in the endoscopic management of early esophageal neoplasia, an annual caseload of at least 10 new cases per endoscopist with esophageal endoscopic resection and 10 new cases per endoscopist with endoscopic ablation is required.

PMID:
42785362
Bibliographic data and abstract were imported from PubMed on 25 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement